The Kinetix Group and Pfizer Health Equity Work Recognized by PM360
The Kinetix Group and Pfizer Health Equity Work Recognized by PM360
NEW YORK, March 29, 2024 /PRNewswire/ -- The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer's atopic dermatitis interactive guide for varying skin tones.
紐約，2024年3月29日 /PRNewswire/ — Kinetix集團（TKG）和輝瑞炎症與免疫學因其最近的健康公平計劃獲得了 PM360 製藥選擇獎。該獎項認可了輝瑞針對不同膚色的特應性皮炎互動指南。
The Pfizer Inflammation and Immunology Strategic Customer Group originally developed the idea to address a gap in equitable patient and provider education resources surrounding atopic dermatitis. The team partnered with TKG to drive awareness for patients with skin of color.
輝瑞炎症和免疫學戰略客戶小組最初提出這個想法是爲了解決圍繞特應性皮炎的公平患者和提供者教育資源方面的差距。該團隊與TKG合作，提高了有色膚色患者的認識。
"I am proud to be a part of a company like TKG, where there is a genuine commitment to addressing health equity and social determinants of health. TKG not only cares about these issues but actively collaborates with others in the industry who share the same dedication to making a difference for patients. Being recognized for my contribution is a significant accomplishment, and it is encouraging to see a growing awareness and concern for these critical issues," said Haley Toomer, manager and member of the winning team.
“我很自豪能加入像TKG這樣的公司，該公司真誠地致力於解決健康公平和健康的社會決定因素。TKG不僅關心這些問題，而且積極與業內其他有着同樣致力於爲患者帶來改變的奉獻精神的人合作。我的貢獻獲得認可是一項重大成就，看到人們對這些關鍵問題的認識和關注日益增強，令人鼓舞。” 獲勝團隊經理兼成員海利·圖默說。
As an industry-voted award, the Pharma Choice Awards celebrate the greatest healthcare and life science creatives, chosen by those who know the industry best. Viewers can vote for their favorite entries in 14 categories including Direct-To-Consumer/Direct-To-Patient, Multichannel, Multicultural, Unbranded and more.
作爲行業投票的獎項，Pharma Choice Awards旨在表彰由最了解行業的人選出的最偉大的醫療保健和生命科學創作者。觀衆可以在14個類別中投票選出自己喜歡的參賽作品，包括直接面向消費者/直接面向患者、多渠道、多元文化、無品牌等。
"At TKG, we wake up every day driven to find novel ways to speed patient access to lifesaving medication," said Sarah McNulty, president of TKG. "Our business charter involves meeting patients where they are to holistically address their needs. This PM360 award is particularly meaningful because it celebrates the inclusive work that we partner with clients to deliver and our company culture, which values diversity and inclusivity."
他說：“在TKG，我們每天醒來都在努力尋找新方法來加快患者獲得救生藥物的速度。” 莎拉·麥克納爾蒂，TKG 總裁。“我們的商業章程包括在患者所在的地方與他們會面，以全面滿足他們的需求。這個 PM360 獎項特別有意義，因爲它旨在表彰我們與客戶合作交付的包容性工作，以及我們重視多元化和包容性的公司文化。”
For more information about the award, visit here or contact [email protected].
有關該獎項的更多信息，請訪問此處或聯繫 [email protected]。
The Kinetix Group (TKG)
Kinetix 集團 (TKG)
The Kinetix Group, a healthcare strategic advisory and marketing agency, is a part of Petauri. TKG empowers life science companies to effectively engage with health system and payer customers. With market access expertise, deep relationships, and connections that span the healthcare ecosystem, TKG is uniquely positioned to understand its clients' customers and design impactful solutions. Its core areas of focus are organized customers, market access, and real-world evidence. To learn more, visit .
醫療保健戰略諮詢和營銷機構Kinetix集團是Petauri的一部分。TKG使生命科學公司能夠有效地與衛生系統和付款人客戶互動。憑藉市場準入專業知識、深厚的關係和跨越醫療保健生態系統的聯繫，TKG在了解客戶客戶和設計有影響力的解決方案方面處於獨特的地位。其核心關注領域是有組織的客戶、市場準入和真實證據。要了解更多信息，請訪問。
SOURCE The Kinetix Group
來源 Kinetix 集團
譯文內容由第三人軟體翻譯。